• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Monthly, September 2011

The CenterWatch Monthly, September 2011

September 1, 2011
CenterWatch Staff

Integrated CRO alliances growing but poorly executed

Results from a new CenterWatch survey show CROs generally believe that while the prevalence of integrated alliances with sponsors will grow in the next three to five years, many sponsors fall short when managing these more sophisticated relationships. In the survey, the first to measure how well sponsors are handling these newer forms of outsourcing relationships, CROs generally gave those companies with more strategic, integrated relationships higher “good/excellent” ratings than those in traditional transactional relationships. Analysis suggests that while many sponsors want to form integrated alliances, many are struggling with how to leverage...

Sites tackle the financial challenges of industry change

Between the weak economy and consolidation in the pharmaceutical industry, investigative sites continue to struggle to make ends meet. They cite the dearth of high-quality studies and increasing sponsor attempts to push costs along to the site level, as well as ongoing difficulty with collecting payments in a timely manner. To weather the storm, sites are marketing themselves more aggressively and becoming more efficient financial managers by

Eye On Cephalon

Cephalon describes itself as “a global biopharmaceutical company driven to expand the boundaries of science to improve human health… with first-in-class therapeutics” since it was founded in 1987 as a biotech startup. Through its diverse research pipeline and approved medications in Oncology, Neurology (including pain control), Immunology and Cardiology, Cephalon has become one of the world’s... 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

 

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing